Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Chemogenetic Kinase Arrays, Peakdale
September 2006
SHARING OPTIONS:

Peakdale Molecular Ltd announced the enhancement of its drug discov­ery capabilities through the introduc­tion of Peakfinder Chemogenetic Arrays, which are focused collec­tions of drug-like molecules targeted towards specific receptor families and pre-optimised to increase robustness and bioavailability in humans. The lat­est Peakdale array will be targeted toward protein kinases. Peakfinder arrays are designed using Peakradar, a computer-aided drug design tool which incorporates information from ADMET profiles, hERG-free solubilising groups and 3D-QSAR models to direct the synthesis of focused arrays with a high-level of compound diversity.
 
Peakdale Molecular Ltd.
www.peakdale.co.uk.
+44 (0)1260 296500

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.